Renal Denervation in Focus: 2024 ESC Guidelines Update
Published: 29 October 2024
-
Views:
2115
-
Likes:
7
-
Views:
2115
-
Likes:
7
-
10m 8s
Overview
Explore the latest European Society of Cardiology (ESC) guidelines on renal denervation (RDN) and what they mean for clinicians.
This video series delves into the new recommendations and explains how they fit into the broader context of existing guidelines. Prof Andrew Sharp and Dr Joost Daemen discuss how these updates might influence daily practice, addressing whether we’ll see more frequent use of RDN in the future. The necessary steps are explored to ensure that RDN becomes a standard part of routine care. Ideal for busy clinicians, this content provides actionable insights into integrating these guidelines into practice.
More from this programme
Part 1
ESC Guidelines 2024 – What’s New?
| 1 session | |
| ESC Guidelines 2024 – What’s New? | Watch now |
Part 2
Putting ESC Guidelines Into Clinical Practice
Faculty Biographies
Andrew SP Sharp
Professor of Cardiology
Prof Andrew Sharp is a Professor of Cardiology at the University College Dublin and The Mater Misericordiae Hospital, Dublin, IE. Andrew qualified from Edinburgh Medical School in 1998. He was appointed as a Consultant Cardiologist at the Royal Devon and Exeter Hospital in 2011 and Honorary Associate Professor by the University of Exeter in 2018 before moving to the University Hospital of Wales in Cardiff in the summer of 2019.
Andrew conducted his early training at the Royal Infirmary of Edinburgh, before moving to London for his senior clinical training, completing the prestigious Milan-Imperial Interventional Cardiology Fellowship programme. Dr Sharp was awarded an MD postgraduate research degree from the University of Edinburgh for his work on the hypertensive heart and his current research interests include device-based treatments for hypertension, pulmonary embolism, intracoronary imaging and coronary physiology.
Andrew's specialist interests include the…
Joost Daemen
Interventional Cardiologist
Dr Joost Daemen is a senior interventional cardiologist at the Thorax Center, Erasmus MC, Rotterdam, NL. Dr Daemen obtained his degree in medicine at the Erasmus University Medical Center. He is actively involved in several drug-eluting stent trials and is Principal Investigator of four trials focusing on the safety and efficacy of renal sympathetic denervation in hypertension, heart failure, vasospastic angina and heart failure. Dr Daemen is a member of the editorial board of EuroIntervention and the Netherlands Heart Journal, member of Young ICIN, and has completed courses in biomedical statistics and device training.
Comments